Mikulec A A, Kowalczyk K A, Pfitzinger M E, Harris D A, Jackson L E
Department of Otolaryngology, Saint Louis University, 3635 Vista, St Louis, MO 63110, USA.
J Laryngol Otol. 2010 Apr;124(4):374-6. doi: 10.1017/S002221510999209X. Epub 2009 Nov 25.
To determine the degree of association, if any, between benign paroxysmal positional vertigo and osteoporosis, both of which are disorders of impaired calcium carbonate homeostasis.
A retrospective chart review was undertaken in two otology clinics to assess the prevalence of treated osteoporosis in 260 women with and without benign paroxysmal positional vertigo, between the ages of 51 and 80 years.
There was a statistically significant, negative association between benign paroxysmal positional vertigo and treated osteoporosis in women aged 51 to 60 years. We also observed a trend towards a negative association for women in their 60s, and for the group as a whole.
Osteoporosis, or the medication used to treat it, may provide protection against benign paroxysmal positional vertigo.
确定良性阵发性位置性眩晕与骨质疏松症之间是否存在关联程度，这两种疾病均为碳酸钙体内稳态受损的病症。
在两家耳科诊所进行回顾性病历审查，以评估260名年龄在51至80岁之间患有和未患有良性阵发性位置性眩晕的女性中接受治疗的骨质疏松症患病率。
在51至60岁的女性中，良性阵发性位置性眩晕与接受治疗的骨质疏松症之间存在统计学上显著的负相关。我们还观察到60多岁的女性以及整个群体存在负相关的趋势。
骨质疏松症或用于治疗它的药物可能对良性阵发性位置性眩晕起到保护作用。
